A Phase 1b/2 Dose-Escalation and Cohort-Expansion Study to Determine the Safety and Efficacy of BGB-11417 as Monotherapy, in Combination With Dexamethasone and Carfilzomib/ Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma and t(11; 14)

Lymphome inkl. Morbus Hodgkin, Multiples Myelom und Chronisch Lymphatischer Leukämie (CLL)

Plasmozytom (Multiples Myelom)

Non-Hodgkin Lymphome (inkl. Chron. Lymphat. Leukämie, CLL)

Translokation

t(11;14)

Phase IB/II

BGB-11417-105

Zweitlinie

National acute promyelocytic leukemia (APL) observational study NAPOLEON&#8208;Register der Deutschen AML Intergroup

Leukämien

Akute myeloische Leukämie (AML)

Fusion Transcript of PML/RARa

Others

t(15;17)

NAPOLEON-Register

Erstlinie

Comprehensive Cancer Center Mainfranken

Studien des CCC Mainfranken